Dr. Daniel Turudic, Croatia
HLA-DQ: The dominant driver of de novo donor-specific antibody-mediated graft failure in pediatric kidney transplantation

Dr. Alicia Paessler, United Kingdom
ABO incompatible LRD kidney transplantation should be offered to children before listing on DD waitlist: results from a 33-year comparative OPTN study

Mr. Jiahao Ge, People's Republic of China
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease

Dr. Marco Schmidt, Germany
The role of endothelial cell senescence in protection from ischemia reperfusion injury

Dr. Julia Steinke, United States
Donor derived cell-free DNA is higher in small pediatric transplant recipients receiving kidneys from obese donors